From January 9 to 10, the National Drug Supervision and Administration Work Conference was held in Beijing. The meeting was guided by Xi Jinping’s thought of socialism with Chinese characteristics in the new era, comprehensively implemented the spirit of the 20th CPC National Congress and the 2nd Plenary Session of the 20th CPC Central Committee, conscientiously implemented the decision-making and deployment of the Central Economic Work Conference and the 3rd Plenary Session of the 20th Central Commission for Discipline Inspection, summarized the work of 2023, analyzed the current situation, and deployed the key tasks of the work of drug supervision and management in 2024. Luo Wen, secretary of the party group and director of the General Administration of Market Supervision, attended the meeting and delivered a speech. Li Li, member of the party group of the General Administration of Market Supervision, secretary of the party group and director of the State Drug Administration (SDA), made a work report. Xu Jinghe, Zhao Junning, Huang Guo and Lei Ping, members of the party group and deputy directors of the State Drug Administration (SDA), the Director of Drug Safety of the SDA, and the responsible comrades of the Discipline Inspection Group of the Central Commission for Discipline Inspection and Supervision of the State Supervisory Commission of the Central Commission for Discipline Inspection and Supervision of the State Council of the State Council of the State Council of the State Council of the Market Supervision Administration (SCMCA) attended the meeting.
The meeting pointed out that over the past year, the national drug regulatory system adhere to Xi Jinping new era of socialism with Chinese characteristics as a guide, conscientiously implement the “four most stringent” requirements, talk about politics, strong supervision, safety, development, and people’s livelihoods to achieve new results, drug supervision work to a new level. First, the Party’s leadership has been comprehensively strengthened, improve the implementation of General Secretary Xi Jinping’s important instructions and instructions and the CPC Central Committee’s decision-making and deployment of the system and mechanism, carry out a solid theme of education, and actively serve the country’s major strategies, the overall strict governance of the Party to the depth of the promotion. Second, the bottom line of drug safety continues to be firmly established, with multiple measures to implement the strictest supervision, effectively improve the quality of risk and hidden trouble investigation and rectification, and strengthen the dynamic supervision of “two products and one device” in all aspects, so that the national drug safety situation remains generally stable. Thirdly, the effectiveness of stimulating innovation and vitality is obvious, continue to deepen the reform of the review and approval system, accelerate the pace of new drugs and good drugs on the market, continue to do a good job in the review and approval of anti-epidemic drugs and medicines, reform and improve the review and approval mechanism of traditional Chinese medicine, and encourage and support innovation of cosmetic raw materials. Fourthly, the construction of regulatory rule of law has been solidly promoted, and the system of regulations and standards has been continuously improved, publicity and education on the rule of law have been widely carried out, and law enforcement and handling of cases have been intensified, so as to form a strong deterrent to illegal and criminal behaviors. Fifth, the regulatory capacity enhancement has been fruitful, strengthening the construction of regulatory personnel, accelerating the development of intelligent regulation, strengthening the application of regulatory scientific research, and extensively participating in international drug safety governance, and the modernization of drug regulation has been pushed forward in a solid manner.
The meeting emphasized that General Secretary Xi Jinping attaches great importance to and is highly concerned about drug safety, and has repeatedly emphasized that drug safety is related to personal health and life safety, and there is no room for ambiguity, and that the strictest standards, the strictest supervision, the harshest penalties, and the most serious accountability should be put into practice. The national drug regulatory system must adhere to high-quality development as the new era of hard truth, to promote Chinese-style modernization as the biggest political, accurately grasp the Party Central Committee of the new requirements for drug regulation, accurately grasp the new challenges to ensure drug safety, accurately grasp the new situation presented by the innovative development of pharmaceuticals, and effectively strengthen the big picture thinking, bottom line thinking, systems thinking, innovative thinking, thinking of the rule of law, to the drug regulatory work of the actual results for the work of the Party and the country, and to the drug regulatory work of the Party and the country. The meeting pointed out that it is important to do a good job in drug safety in the year 2024, so as to make due contribution to the overall situation of the Party and the country.
The meeting pointed out that to do a good job in drug supervision in 2024, we should adhere to the guidance of Xi Jinping Thought on Socialism with Chinese Characteristics in the New Era, fully implement the spirit of the 20th CPC National Congress and the 2nd Plenary Session of the 20th CPC Central Committee, conscientiously implement the requirements of the “four most stringent”, adhere to the requirements of “making progress amidst stability”, “advancing to promote stability”, and “establishing first and then breaking down”, in accordance with “political, strong supervision, safety, development and people’s livelihood” work idea, the integration of high-quality development and high level of safety, in-depth implementation of drug safety consolidation and enhancement of action, all-round building drug safety bottom line, deepen the reform of drug supervision, enhance the effectiveness of drug supervision, and effectively protect the people’s medication safety and effective, support the pharmaceutical industry High-quality development of the pharmaceutical industry, to promote the modernization of the Chinese style to contribute to the strength of drug supervision.
The meeting made four specific deployments for this year’s drug supervision work. The first is to fight the battle of preventing and controlling drug safety risks. Preventing and resolving drug quality and safety risks as the fundamental task of drug supervision and control work, good risk prevention and control “first move”, continue to deepen the consolidation and enhancement of drug safety action, grasp the key varieties, key enterprises, key links in the supervision and control, and promote the supervision and control responsibility of the drug safety department, the responsibility of territorial management and the responsibility of the main body of the enterprise to through linkage We will continue to deepen the drug safety consolidation and enhancement action, focus on the supervision of key varieties, key enterprises and key links, promote the supervision responsibility of the drug safety department, local management responsibility and enterprise main responsibility through the linkage, and nip the risk in the bud. Second, to create an efficient and fair regulatory environment. Give full play to the role of supervision and guidance, deepen the reform of the review and approval system, actively support pharmaceutical R&D and innovation, promote the development of traditional Chinese medicine heritage and innovation, continue to enhance the level of convenience for enterprises and the public, and promote the construction of a benign cycle of industrial ecology that supports the research and development, production, sales, and clinical application of innovative medicines and equipment. Third, accelerate the pace of modernization of drug supervision. We will strengthen system and means innovation, enhance the construction of the rule of law in drug supervision, continuously improve the level of regulatory informationization, deepen regulatory scientific research and international cooperation, build a team of high-quality professional cadres and talents, and accelerate the enhancement of the effectiveness of drug supervision. Fourth, to promote the development of comprehensive and strict governance of the Party in a deeper and deeper manner. We will seriously study and understand the spirit of General Secretary Xi Jinping’s important speech at the Third Plenary Session of the 20th Central Commission for Discipline Inspection, always maintain self-revolutionary determination, always adhere to the tone of strictness, and comprehensively strengthen the Party’s political construction, ideological construction, organizational construction, style of construction, discipline construction, and system construction, and correct the trees to create a good style of work, and continue to enhance the “three non-corrosive” comprehensive effectiveness, and strengthen the drug supervision and regulation of the Party, as well as to enhance the effectiveness of the Party. The Party has also strengthened its political construction, ideological construction, organizational construction, style construction, disciplinary construction and institutional construction, created a good style of work by both correcting and combining efforts, continuously enhanced the comprehensive effectiveness of “three non-corruptions”, strengthened the spirit of the cadres in the drug supervision team and honed their abilities, and led the high-quality development of the cause of drug supervision by high-quality Party construction.
Comrades from the relevant departments of the central and state organs were invited to attend the meeting. Cadres above the level of deputy secretary of the organs of the State Drug Administration, the main responsible comrades of the party and government of each directly under the unit and the members of the leadership of the directly under the unit in Beijing, the main responsible comrades and the director of the office of the drug regulatory departments of each province, autonomous region, municipality directly under the central government and the Xinjiang Production and Construction Corps attended the meeting.
Hongguan care about your health.
See more Hongguan Product→https://www.hgcmedical.com/products/
If there are any needs of medical comsumables, please feel free to contact us.
hongguanmedical@outlook.com
Post time: Jan-11-2024